Fenwick & West advised TrialSpark on the deal. TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, announced its $156 million Series C financing. The round...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here